GT
ACHN

Glenmede Trust’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History

Glenmede Trust’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,074
Closed -$5K – 2454
2018
Q1 		$5K Hold
2,074
– – ﹤0.01% 2421
2017
Q4 		$5K Buy
+2,074
New +$5K ﹤0.01% 2421